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Assembly factorComplex I (NADH:ubiquinone oxidoreductase) is the largest multimeric enzyme complex of the mitochon-
drial respiratory chain, which is responsible for electron transport and the generation of a proton gradient
across the mitochondrial inner membrane to drive ATP production. Eukaryotic complex I consists of 14 con-
served subunits, which are homologous to the bacterial subunits, and more than 26 accessory subunits. In
mammals, complex I consists of 45 subunits, which must be assembled correctly to form the properly func-
tioning mature complex. Complex I dysfunction is the most common oxidative phosphorylation (OXPHOS)
disorder in humans and defects in the complex I assembly process are often observed. This assembly process
has been difﬁcult to characterize because of its large size, the lack of a high resolution structure for complex I,
and its dual control by nuclear and mitochondrial DNA. However, in recent years, some of the atomic struc-
ture of the complex has been resolved and new insights into complex I assembly have been generated. Fur-
thermore, a number of proteins have been identiﬁed as assembly factors for complex I biogenesis and many
patients carrying mutations in genes associated with complex I deﬁciency and mitochondrial diseases have
been discovered. Here, we review the current knowledge of the eukaryotic complex I assembly process
and new insights from the identiﬁcation of novel assembly factors. This article is part of a Special Issue enti-
tled: Biogenesis/Assembly of Respiratory Enzyme Complexes.nesis/Assembly of Respiratory
+61 3 9479 1266.
.
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1.1. OXPHOS and the mitochondrial respiratory chain
Mitochondrial ATP is produced by the oxidative phosphorylation
(OXPHOS) machinery [1]. OXPHOS couples 2 sets of reactions, the
phosphorylation of ADP and electron transfer through a chain of oxi-
doreductase reactions. In most eukaryotes, the process is carried out
by the respiratory chain, which consists of 5 enzyme complexes
embedded in the mitochondrial inner membrane: complex I (CI,
NADH:ubiquinone oxidoreductase), complex II (CII, Succinate:ubiqui-
none oxidoreductase), complex III (CIII, ubiquinol:cytochrome c oxido-
reductase), complex IV (CIV, cytochrome c oxidase) and complex V (CV,
ATP synthase). OXPHOS begins with the entry of electrons into the
respiratory chain through CI or CII. CI binds and oxidizes NADH and gen-
erates 2 electrons that are transferred through ﬂavin mononucleotide(FMN) and 7 iron–sulfur (Fe–S) clusters to ubiquinone, the ﬁrst electron
acceptor [2]. CII is another electron entry point for the transfer of elec-
trons from succinate to ubiquinone [3]. Electrons from CI or CII are sub-
sequently transferred from reduced ubiquinone (ubiquinol) to CIII,
then to cytochrome c, the second mobile electron carrier, and ﬁnally to
complex IV. CIV is the terminal enzyme in the electron transfer
chain, reducing O2 toH2O byusing the delivered electrons [4]. Coupling
electron transfer, CI also plays a role as a pump to transfer protons out of
the matrix with a stoichiometry of 4 protons to 2 electrons [1,2,5]. The
pathway through complexes I, III and IV pumps a total of 5 protons
per electron that are translocated from the mitochondrial matrix to
the intermembrane space, creating a membrane potential. The trans-
membrane electrochemical potential is then used to promote the con-
formational change of CV, resulting in the generation of ATP [6].1.2. Complex I structure and function
Eukaryotic CI is located in the mitochondrial inner membrane and
protrudes into the matrix to form an L-shaped structure [7]. This
structure consists of a hydrophilic peripheral arm with a hydrophobic
membrane arm lying perpendicular to it. This L-shaped structure is
conserved from NDH-1 in Escherichia coli, which is a homolog of eu-
karyotic CI [8,9], to bovine heart CI [7].
Fig. 1. Schematic graph of mammalian mitochondrial complex I structure. The matrix
arm and the membrane arm form an L-shaped structure, with an angle of 100°. It is
composed of three conserved functional modules: the NADH dehydrogenase module
(N module), the electron transfer module (Q module) and the proton translocation
module (P module). The positions of 14 core subunits are indicated, all of which are
highly conserved from prokaryotes to eukaryotes.
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Thermus thermophiluswas solved and the relative positions of the 8 sub-
units that compose the peripheral arm of CI were deﬁned [10]. The pe-
ripheral arm consists of 2 functional modules, an electron inputmodule
(Nmodule) and an electron output module (Qmodule), and comprises
all redox active cofactors [10] (Fig. 1). The N module contains an NADH
oxidation site with an FMN molecule as the primary electron acceptor,
while the Q module contains a ubiquinone reduction site. Electrons
from the oxidation of NADH are transferred via FMN and a series of
Fe–S clusters to ubiquinone. The membrane arm or the proton translo-
cation module (P module) contains the 3 subunits, ND2, ND4 and ND5
[11] (Fig. 1). They are highly hydrophobic proteins, which contain
around 15 transmembrane stretches, and are antiporter-like subunits
presumably involved in proton-pumping activity [11]. However, how
electron transfer is coupled to proton translocation, either by direct as-
sociation through protein binding sites or indirectly through conforma-
tional changes of the enzyme, remained obscure because of the lack of a
high quality 3-dimensional structure of CI [12,13]. Recently, the X-ray
structures of the membrane domain of CI from E. coli at a resolution of
3.9 Å and of the entire CI from T. thermophilus at a resolution of 4.5 Å
were solved [14]. These ﬁndings deﬁned the positions of all of the sub-
units and revealed the long horizontal α-helical structure of the mem-
brane domain of CI, suggesting that the conformational changes at the
interface of thematrix andmembrane domainsmay drive the long am-
phipathic α-helices in a piston-like motion, thereby leading to proton
translocation. In addition, the low resolution X-ray structure of mito-
chondrial CI from the aerobic yeast Yarrowia lipolyticawas also reported
[15]. The arrangement of functional modules suggested the conforma-
tional coupling of redox chemistry with proton pumping. A long helical
element in theNuoL/ND5 subunit stretches across thematrix face of the
membrane domain of CI and is suggested to be critical for transducing
conformational energy to proton-pumping elements in the distal mod-
ule of the membrane arm.
Bovine (and human) mitochondrial CI consists of 45 different sub-
units with a total molecular weight of ~980 kDa [16,17]. In this re-
view we will use the human nomenclature for complex I subunits,
where nuclear encoded subunits contain the preﬁx “NDU” (NADH-
dehydrogenase-ubiquinone) and mtDNA-encoded subunits are
given the preﬁx “ND” (NADH-dehydrogenase). A number of complex
I assembly factors have been given the preﬁx “NDUFAF” — for NADH-
dehydrogenase (NDU), alpha subcomplex (F), assembly factor (AF),
plus a number indicating when it was ﬁrst named. The reference to
the alpha subcomplex within the abbreviation does not appear to be
substantiated. To limit confusion, the assembly factor proteins are in
lower case within the text.
Seven subunits, ND1–ND6 and ND4L, are encoded by mitochondrial
DNA (mtDNA), and are homologs of the 7membrane subunits inNDH-1,
forming the major part of the membrane domain [1,18]. The mtDNA-
encoded subunits are thought to be involved in proton translocation
and ubiquinone binding, as their bacterial homologs have these func-
tions [1,7]. The remaining 38 subunits are encoded by nuclear DNA
(nDNA) and imported into the mitochondria [18–20].
Seven of the nDNA-encoded subunits, NDUFV1, NDUFV2, NDUFS1,
NDUFS2, NDUFS3, NDUFS7 and NDUFS8, represent the “core sub-
units” in the peripheral arm of CI, catalyzing the oxidation of NADH
and electron transfer [1,21]. TheNmodule, responsible for the oxidation
of NADH, includes at a minimum the NDUFV1, NDUFV2 and NDUFS1
subunits. And theQmodule, responsible for the electron transfer to ubi-
quinone, includes at a minimum the NDUFS2, NDUFS3, NDUFS7 and
NDUFS8 subunits [22] (Fig. 1). The remaining 31 nDNA-encoded sub-
units are referred to as “supernumerary” subunits because they have
no counterparts in NDH-1 [16]. Most of the supernumerary subunits
are not involved in CI enzymatic activity, and their actual function is
still unknown [18]. It has been proposed that the eukaryotic supernu-
merary subunits assist in CI biogenesis and support the structural stabil-
ity of CI [7,17].2. Complex I assembly
The assembly of subunits into CI has proved to be a very complicated
process to characterize due to the large size and numerous subunits of
the enzyme, lack of a detailed crystal structure, and its dual genomic
control. The nDNA-encoded subunits must assemble in coordination
with the hydrophobic mtDNA-encoded subunits to form the properly
functioning mature complex; however, the assembly pathway is still
not completely understood.
It has been suggested that the co-evolutionary structural relationship
between CI subunitsmay be reﬂected by the order of assembly and com-
position of assembly intermediates [23]. Based on this concept, a num-
ber of model systems have been employed to study the assembly of
eukaryotic CI, in various organisms such as the green alga Chlamydomonas
reinhardtii [24–28], the fungusNeurospora crassa [29–36], the nematode
Caenorhabditis elegans [37], and culturedmammalian cell lines [38–42].2.1. Assembly of complex I in C. reinhardtii
In C. reinhardtii, the assembly of mtDNA-encoded subunits has
been well characterized. The absence of ND4 or ND5 led to the accu-
mulation of a 700-kDa subcomplex, i.e. partial assembly of an incom-
plete complex. In contrast, mutations in ND1 or ND6 subunit resulted
in a failure to detect the mature 950-kDa holo-CI or the 700-kDa sub-
complex [24,25]. Based on these results, it was proposed that the ND4
and ND5 subunits are incorporated at a late stage of assembly after
the incorporation of the ND1 and ND6 subunits. Investigations of
the role of ND3 and ND4L in assembly resulted in the generation of
the ﬁrst assembly model for C. reinhardtii, in which a 200-kDa nuclear-
encoded subcomplex, containing the 76-kDa (NDUFS1) and 49-kDa
(NDUFS2) subunits, is anchored to the membrane by combining with
ND1, ND3, ND4L and ND6 forming the 700-kDa subcomplex and subse-
quently expanded by the addition of ND4 and ND5 to generate the holo-
CI [26]. In subsequent investigation of the role of ND5, the lack of ND5
prevented the assembly of the holo-CI, but allowed the assembly in
low amount of the 700-kDa subcomplex, which is loosely bound to the
mitochondrial membrane [27]. The mass spectrometry analysis of the
700-kDa subcomplex identiﬁed eleven homologs to human CI subunits:
nine (NDUFV1, NDUFV2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS7,
NDUFS8 and NDUFA12) are associated with the matrix arm and two
(ND3 and NDUFA9) are located at the junction between the matrix
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fragment is formed by the addition of hydrophilic and hydrophobic sub-
units to the 200-kDa fragment and then the 700-kDa complex is ﬁrmly
anchored to the membrane by attachment of the 250-kDa hydrophobic
module containing ND4 and ND5. These subunits ND4 and ND5 proba-
bly have a crucial role in the assembly of the distal part of themembrane
arm of CI which is suggested to be critical for anchorage of the whole
complex within the mitochondrial inner membrane [27,28].
2.2. Assembly of complex I in N. crassa
CI assembly in the aerobic fungusN. crassa has also beenwell studied
through the characterization of mutant strains generated by systematic
introduction of mutations in CI genes [31–36]. Mutants lacking subunits
of thematrix arm could not assemble CI and accumulated themembrane
armof the complex [34]. Conversely, amutant lacking a nuclear-encoded
subunit of the membrane arm accumulated the matrix arm and 2 inter-
mediates of themembrane arm [43]. From such studies, it was proposed
that CI inN. crassa is assembled via evolutionarily conservedmodules. In
this model, the hydrophilic matrix arm is formed separately while the
membrane arm is constructed from ~200-kDa and ~350-kDa intermedi-
ates. The small intermediate contains the ND2 and ND5 subunits, while
the large intermediate contains ND1, 3, 4, 4L and 6 [30,32]. Although
these ﬁndings provided the ﬁrst detailed model of mitochondrial CI
assembly in a eukaryote, the integration of subunits into different
modules is not consistent with recent insights into the molecular archi-
tecture of CI [14,15]. Furthermore, its application tomammalian systems
is limited sincemammalian complex I contains additional subunitswhen
compared to its fungal counterpart.
2.3. Complex I assembly in mammals
Assembly studies in rodent and human ND-subunit mutant cell
lines have demonstrated that subassemblies of nDNA-encoded CI
subunits could be formed in the absence of mtDNA-encoded subunits
[44,45]. Cells lacking mtDNA, which lose all of the mtDNA-encoded
subunits, maintain the levels of some nDNA-encoded subunits of the
peripheral arm. They contain a subcomplex of the peripheral arm
that consists of, at least, NDUFS2, NDUFS3 and NDUFS8 [44]; there-
fore, it has been suggested that the presence of the mtDNA-encoded
subunits is not required for the formation of the peripheral arm sub-
complex [45] (Fig. 2).
However, the entry points of the mtDNA-encoded subunits in the
CI assembly process and their roles in the stability of CI had remained
elusive. Recent research using several mouse cell lines deﬁcient for
ND4, ND6, and combination of ND6 and ND5 proposed ﬁve entry
points of the mtDNA-encoded subunits in the CI assembly process
[46]. This study deﬁned a ﬁrst entry point for ND1 in the ~400 kDa-
subcomplex and a second entry point for ND2, ND3 and ND4L in the
~460 kDa-subcomplex. Subsequently, ND4, ND6 and ND5 appear to
be incorporated into CI complex in order at a third, fourth and ﬁfth
entry point, respectively.
A useful model system using Chinese hamster cells has also clariﬁed
the function of some CI subunits in the CI assembly process [40]. For
example, NDUFA1 has been shown to be important for CI assembly
[47]. The insertion and stabilization of NDUFA1 in the mitochondrial
inner membrane were shown to require mtDNA-encoded subunits,
in particular, ND4 andND6 [48]. NDUFA1 is also unstable in the absence
of other membrane domain subunits like NDUFB11 [40]. Chinese
hamster ﬁbroblasts also revealed that the stability of the peripheral
arm subunits NDUFS1, 2, 3, 7, 8 and NDUFV1 and 2 were unaffected
by the absence of NDUFA1, although holo-CI was not assembled
[40]. These data suggest that the peripheral arm can be assembled
in the absence of themembrane arm, similar to its assembly inN. crassa
[29]. NDUFA1 was also suggested to form an assembly intermediate
consisting of mtDNA- and nDNA-encoded subunits and to serve as amembrane anchor to which membrane subunits are attached during
CI assembly [48]. Furthermore, recent bioinformatic analyses of the co-
evolution of CI subunits coupledwith yeast two-hybrid studies revealed
the interaction of human NDUFA1 with ND1 and ND4, and the interac-
tion of humanNDUFC2withND4 [49]. Theﬁndings reinforce the impor-
tant role of NDUFA1 in forming an assembly intermediate composed of
mtDNA-and nDNA-encoded subunits. The direct physical interaction
between NDUFC2 and ND4 indicates that these subunits may be incor-
porated into themembrane arm together. Since ND1, ND4 and NDUFA1
are essential for the assembly of the membrane arm of complex I,
NDUFC2 may be also important for the assembly process.
Other supernumerary subunits have also been proposed to assist
in CI biogenesis and support the structural stability of CI. The analysis
of sequence conservation revealed intra-molecular disulﬁde bridges
and the intermembrane space localization of three CX9C-containing
subunits in human: NDUFS5, NDUFB7 and NDUFA8 [50]. The presence
of an intermembrane space targeting signal, in conjunction with a
CX9C domain (which is found in all known and predicted Mia40 sub-
strates [51]), and the absence of a canonical mitochondrial targeting
signal suggest the insertion of the three subunits into the complex di-
rectly from the intermembrane space. The predicted sizes of these
CX9C domain-containing subunits would ﬁt within 3 intermembrane
protrusions in the membrane arm in the recent bovine CI structure
determinedby 3D electronmicroscopy [52]. Itwas proposed that the sta-
bilization of the membrane arm of CI by these subunits from the inter-
membrane space might be necessary for eukaryotic CI stability [50].
The import of the three subunits, NDUFS5, NDUFB7 and NDUFA8, to
the intermembrane space via the Mia40 pathway was supported by se-
quence based analysis which predicts the sub-compartment localization
of mitochondrial proteins [53]. In addition, the electron microscopic
analysis of CI decoratedwithmonoclonal antibody against NDUFA8 con-
ﬁrmed its predicted localization at the proximal end of the membrane
arm on the intermembrane space side [53]. It is interesting to note that
the CI assembly process would involve multiple import pathways that
direct nDNA-encoded subunits to either the matrix or intermembrane
space side.
In human cells, several assemblymodels have been proposed by con-
ditional assembly systemswhere the assembly process is disturbed [39],
by tracing assembly intermediates in wild-type cell lines using pulse-
chase techniques, by tracking the assembly of individual nuclear-
encoded subunits using an in vitro mitochondrial import and assembly
assay [41], and bymonitoring the assembly pattern of the green ﬂuores-
cent protein-taggedNDUFS3 subunit and its progression into themature
holoenzyme [42].
Using a conditional assembly system by removing a block inmtDNA-
encoded protein translation, it was proposed that the peripheral matrix
arm (containing at least NDUFS2, 3 and 4, NDUFA9 and NDUFV2) and
themembrane arm (containing at least ND1, ND6 and NDUFB6) are as-
sembled separately [39], consistent with the modular assembly path-
way in N. crassa [29]. A subsequent study by the same group
monitored the assembly pattern of the green ﬂuorescent protein-
tagged NDUFS3 subunit and its progression into the mature holoen-
zyme [42]. The model proposed that an early peripheral arm assembly
intermediate containing NDUFS2 and NDUFS3 is membrane anchored
by ND1 prior to expansion with additional membrane arm and periph-
eral arm subunits. Interestingly, this proposed assemblymodel is differ-
ent from the modular assembly pathway in N. crassa [29] (Fig. 2).
The model was supported by another study monitoring the as-
sembly of subunits in the presence of endogenous CI using radiolabel-
ing techniques [41]. In this study, a small peripheral complex is
membrane anchored to a subcomplex containing membrane arm
subunits. A smaller subcomplex containing at least ND1 is detected,
to which ND2, 3 and 6 are presumably added. This ﬁnding is different
from the recent proposed model in which ND6 appears to be incorpo-
rated at a later step than ND4 [46]. Because the recent crystal struc-
tures of the membrane arm of bacterial CI revealed that the ND6
Fig. 2. The assembly model of human complex I biogenesis. In the early assembly stages, the core subunits NDUFS2 and NDUFS3 form a small hydrophilic assembly complex, which
further expands by the incorporation of hydrophilic subunits such as NDUFS7, NDUFS8 and later NDUFA9. This peripheral complex, together with a small membrane complex con-
taining mtDNA-encoded subunit ND1, forms a ~400 kDa assembly intermediate. This ~400 kDa complex incorporates with a ~460 kDa membrane complex containing ND3, ND6,
ND2, ND4L and NDUFB6 to form a ~650 kDa complex. With the association of another membrane complex having ND4, ND5 and probably NDUFC2, an ~830 kDa assembly inter-
mediate is formed. Meanwhile, a hydrophilic complex, NADH: dehydrogenase module (N module) is assembled by some nDNA-encoded subunits directly or indirectly involved in
binding and oxidizing NADH. With the addition of the N module and remaining subunits (such as the intermembrane space subunits NDUFA8 and NDUFS5), mature complex I is
assembled. The core subunits are colored with red, the rest of nDNA-encoded subunits are colored with blue. The mtDNA-encoded-subunits are in green.
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ND3 and ND4L while ND5 and ND4 are located at the periphery of
the membrane arm [14], ND6 is presumably assembled at an earlier
step than ND5 and ND4. However, this entry point of ND6 in mamma-
lian CI assembly requires further investigation due to evolutionary di-
vergence. After assembly of peripheral and membrane intermediates,
the subcomplex is expanded with membrane arm subunits including
NDUFA9, NDUFA10 and NDUFB9. Subsequently, the N module con-
taining NDUFV1, 2, 3, NDUFS4 and NDUFS6 is added (Fig. 2). Interest-
ingly, nDNA-encoded subunits appeared to assemble directly into
mature pre-existing CI much faster than mtDNA-encoded subunits.
This ﬁnding leads to the proposal that newly imported nDNA-
encoded subunits may be exchanged with pre-existing incorporated
subunits [41].
2.4. Complex I deﬁciency with CI subunit mutations
CI deﬁciency is the most common respiratory chain defect in
human disorders [54–56]. It has a wide range of clinical presentations,
from lethal infantile mitochondrial disease to isolated myopathy, or
adult onset neurodegenerative disorders and it can be caused by muta-
tions in both nuclear and mtDNA [54,57–59]. To date, genetic defects
causing isolated CI deﬁciency have been reported for all of the 14 core
subunits, including the 7 mtDNA-encoded subunits and the 7 nDNA-
encoded subunits NDUFV1 [60], NDUFV2 [61], NDUFS1 [62,63],
NDUFS2 [64,65], NDUFS3 [66], NDUFS7 [67] and NDUFS8 [68,69]
(Table 1). In addition, pathogenic mutations in genes encoding super-
numerary subunits such as NDUFS4 [70,71], NDUFS6 [72], NDUFA1
[73], NDUFA2 [74], NDUFA10 [75], NDUFA11 [76] and NDUFA12 [77]
have also been reported (Table 1). Not much is known about the role
of these supernumerary subunits, but the presence of disease-causing
mutations in these genes indicates that at least someof themare impor-
tant for proper CI function. Indeed, mutations in NDUFS4, NDUFS6,
NDUFA2 and NDUFA10 lead to decreased levels of assembled holo-CI
with the accumulation of CI subcomplexes, which indicates a distur-
bance in the assembly and/or stability of CI [70,72,74,75].
Roles of mtDNA-encoded CI subunits in CI assembly have been
well studied in patients with mutations in these subunits. It appearsthat mutations in MTND1 and MTND6 cause gross deﬁciency of as-
sembled CI [78,79], while ND4 and ND6 are essential for the integra-
tion of other mtDNA-encoded subunits into the complex [78,80]. Cells
derived from a patient with a mutation in MTND2 also showed the CI
assembly defect with accumulation of subcomplexes [81]. On the con-
trary, mutations in MTND3 and MTND5 gave a relatively normal as-
sembly proﬁle [82,83]. As mentioned above, since ND5 is located at
the periphery of the membrane, it may be the last of the ND subunits
to assemble [14] (Fig. 2). However, the different effects of mtDNA
mutations on CI assembly could also be partly attributed to the pro-
portion of mutant mtDNAs and the nature of amino acid substitutions
affecting protein function.
CI-deﬁcient cells from patients have been utilized to determine how
speciﬁc subunits including nDNA-encoded subunits are assembled into
CI [38,84]. In these studies, various stalled assembly intermediateswere
identiﬁed. Based on the ﬁndings, a model for CI assembly in which the
matrix and membrane arm subunits are found together as early-stage
intermediates was proposed. This model for human CI assembly
does not correspond to the modular, evolutionarily conserved
model proposed for CI assembly in N. crassa in which the matrix
and membrane arms are assembled via independent pathways
[29]. However, this CI assembly process is generally similar to the
models proposed by tracing assembly intermediates in wild-type
cell lines [41,42] (Fig. 2).3. Assembly factors
The assembly of such a large number of subunits into the mature
holo-CI involves a number of assembly factors. These assembly factors
are not part of the ﬁnal structure of the holo-CI, but they are involved
in CI biogenesis and are found in some CI intermediates, indicating
their functions in CI assembly/stability. It is apparent that some as-
sembly factors are involved in the biogenesis of speciﬁc subunits
while others appear to stabilize assembly intermediates. There are
also other factors that would be involved in the biogenesis of other
proteins and their complexes. Here, we will concentrate on assembly
factors which are speciﬁc for CI biogenesis.
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Homozygosity mapping of a family with a lethal neonatal form of
CI deﬁciency and the use of microcell-mediated chromosome transfer
led to the identiﬁcation of a novel assembly factor encoded by the
C20orf7 gene [85] (Table 2). A homozygous missense mutation in
C20orf7 segregated with the disease in the family and resulted in a
marked isolated CI deﬁciency in skeletal muscle, liver and skin ﬁbro-
blasts of the proband. Knockdown of C20orf7 expression in control
cells using lentiviral-mediated RNA interference (RNAi) caused a
marked decrease in CI activity. Analyses of mtDNA-encoded protein
translation in mitochondria from the patient revealed the loss of the
CI ND1 subunit, and a ~400-kDa membrane arm intermediate con-
taining ND1 was not formed [85]. These observations suggested that
C20orf7 is involved in the assembly or stability of an early CI assembly
intermediate that contains the ND1 subunit (Table 2). Interestingly,
C20orf7 possesses a predicted S-adenosyl-methionine (SAM)-dependent
methyltransferase fold and itmaymethylate proteins, RNA, or DNAwith-
in mitochondria [86,87]. As far as protein methylation is concerned, only
2 methylated subunits have been detected in CI subunits [88]. One of
them is NDUFS2, which harbors a methylated arginine, and the other is
NDUFB3. At least 2 highly conserved histidines are methylated in
NDUFB3 [89], and this subunit is located in themembrane arm of CI con-
taining ND1. Recently, a second family carrying a homozygous C20orf7
mutationwith Leigh syndromewas reported [90]. Thismutation affected
the predicted SAM-dependent methyltransferase domain of C20orf7.
Although the interaction of C20orf7 with NDUFB3 and its subsequent
methylation remain to be investigated further, it is possible that this
post-translational modiﬁcation of the subunit plays a role in the assem-
bly or stability of the mature CI. Recently, linkage analysis and DNA
sequencing identiﬁed a new homozygous C20orf7mutation in ﬁve pa-
tients from two families [91]. Differing from the two previous reportedTable 1
Known complex I subunit defects which cause mitochondrial disease.
Human Bovine homologue Posit
I
Mitochondrial DNA encoded
subunits
ND1 ND1 P mo
ND2 ND2 P mo
ND3 ND3 P mo
ND4 ND4 P mo
ND4L ND4L P mo
ND5 ND5 P mo
ND6 ND6 P mo
Nuclear DNA encoded
subunits
NDUFA1 MWFE
NDUFA2 B8
NDUFA10 42 kDa
NDUFA11 B14.7
NDUFA12 B17.2
NDUFS1 75 kDa N mo
prote
(N1b
NDUFS2 49 kDa Q mo
NDUFS3 30 kDa Q mo
NDUFS4 18 kDa N mo
NDUFS6 13 kDa N mo
NDUFS7 PSST Q mo
prote
NDUFS8 TYKY Q mo
prote
NDUFV1 51 kDa N mo
prote
NDUFV2 24 kDa N mo
prote
a LHON, Leber Hereditary Optic Neuropathy.
b MELAS, Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes.
c L.S., Leigh Syndrome or Leigh-like Syndrome.
d LIMD, Lethal Infantile Mitochondrial Disease.C20orf7 defects associated with isolated CI deﬁciency, the patients
showed a combined OXPHOS defect with not only CI but also CIV deﬁ-
ciency. Notably, decreased CIV was also observed by knockdown of
C20orf7 expression in control cells using lentiviral-mediated RNAi
[85]. These ﬁndings raise the possibility that C20orf7 may play a role
in the post transcriptional modiﬁcation of one or several proteins of im-
portance for CI and CIV function and/or assembly [85,91]. Although the
precise pathogenic mechanism is still unclear, a C20orf7 defect should
be considered not only in isolated CI deﬁciency but also in combination
with decreased CIV activity [91].
3.2. Ndufaf4 (C6orf66)
Homozygosity mapping of patients with infantile mitochondrial
encephalopathy or antenatal cardiomyopathy attributed to isolated
CI deﬁciency led to the identiﬁcation of an assembly factor encoded
by the Ndufaf4 (C6orf66) gene [92] (Table 2). A missense mutation
in a conserved residue of Ndufaf4 was associated with a reduction
in its mRNA level in ﬁbroblasts and a signiﬁcant decrease of Ndufaf4
protein in muscle. Isolated mitochondria from this patient's muscle
have only ~30% residual mature CI, with the accumulation of 2 com-
plexes that were smaller than the CI holoenzyme, which may be stalled
assembly intermediates. One of them resembled the ~830-kDa interme-
diate associatedwith the assembly factor B17.2L (see later). Dysfunction
of CI was due to a direct consequence of this mutation, as demonstrated
by the functional restoration of CI activity upon transfection of the
patient's cells with wild-type Ndufaf4 cDNA.
3.3. Ndufaf3 (C3orf60)
Homozygosity mapping and gene sequencing of 5 CI-deﬁcient
patients from 3 different families identiﬁed mutations in the Ndufaf3ion in complex Clinical diagnosis Ref.
dule LHONa, MELASb [79,129]
dule L.S.c [81]
dule L.S., LIMDd [82,111,130–132]
dule LHON, L.S. [80,133,134]
dule LHON [135]
dule L.S., MELAS, LHON [83,111,127,136]
dule L.S., LHON, dystonia [127,137,138]
L.S., mitochondrial encephalopathy [73,139,140]
L.S. [74]
L.S. [75]
Mitochondrial encephalopathy,
cardiomyopathy, LIMD
[76]
L.S. [77]
dule; Fe–S
in
, N4, N5)
L.S., leukodystrophy [62,63,141,142]
dule L.S., cardiomyopathy, mitochondrial
encephalomyopathy, LIMD
[64,65]
dule L.S. [66]
dule L.S. [70,71,107,111]
dule LIMD [72,143]
dule; Fe–S
in (N2)
L.S. [67,144]
dule; Fe–S
in (N6a, N6b)
Mitochondrial encephalopathy,
cardiomyopathy, leukodystrophy, L.S.
[68,69,111]
dule; Fe–S
in (N3), FMN
LIMD, leukodystrophy, mitochondrial
encephalopathy, L.S.
[60,62,107,111,127]
dule; Fe–S
in (N1a)
Cardiomyopathy, mitochondrial
encephalopathy
[61,128]
Table 2
Pathogentic mutations in known complex I assembly factors.
Assembly
factor
Patient studies Assembly defect description Ref.
Clinical diagnosis Mutations
C20orf7 LIMDa Homozygous: c.719TNC (p.L229P)
The translation or stabilization of the ND1 subunit is impaired,
which prevents the assembly of the ~400 kDa assembly
intermediate containing ND1.c
[85,90,91]
L.S.b Homozygous: c. 477ANC (p.L159F)
L.S. Homozygous: c. 749GNT (p.G250V)
Ndufaf3
(C3orf60)
LIMD Homozygous: c.229GNC (p.G77R);
The peripheral subcomplex containing NDUFS2, FS3, FS7, and FS8
fails to be inserted into the membrane, resulting in the impaired
assembly of the ~400 kDa assembly intermediate.
[92,93]
LIMD Homozygous: c.365GNC (p.R122P)
LIMD Compound heterozygous: c.2TNC
(p.M1T); c.365GNC (p.R122P)
Ndufaf4
(C6orf66)
LIMD, antenatal
cardiomyopathy
Homozygous: c.194TNC (p.L65P)
Ndufaf1
(CIA30)
Cardioencephalomyopathy Compound heterozygous: c.1140ANG
(p.K253R); c.1001ANC (p.T207P)
The ~460 kDa assembly intermediate containing ND2, ND3 and
ND4L is not formed, and the ~400 kDa assembly intermediate is
accumulated initially, but quickly turned over.
[95,96]
ACAD9 Cardiomyopathy, hearing loss,
short stature, exercise
intolerance
Homozygous: c.1553GNA (p.R518H)
ACAD9 mutations cause decreased levels of NDUFAF1, Ecsit and
mature CI.
[102–104]
Encephalopathy,
cardiomyopathy
Compound heterozygous: c.187GNT
(p.E63X); c.1237GNA (p.E413H)
Exercise intolerance Homozygous: c. 1594CNT (p.R532W)
Exercise intolerance Compound heterozygous: c.380GNA
(p.R127Q); c.1405CNT (p.R469W).
Cardiomyopathy,
mitochondrial encephalopathy
Compound heterozygous: c.130TNA
(p.F441); c.797GNA (p.R266Q).
Cardiomyopathy, exercise
intolerance
Compound heterozygous: c. 130TNA
(p.F441); c.797GNA (p.R266Q).
Cardiomyopathy,
mitochondrial encephalopathy
Compound heterozygous: c.797GNA
(p. R266Q); c.1249CNT (p.R417C)
Cardiomyopathy,
mitochondrial encephalopathy
Compound heterozygous: c.976GNA
(p. A326P); c.1594CNT (p. R532W)
Ndufaf2
(B17.2L or
NDUFA12L)
Mitochondrial encephalopathy Homozygous: c.182CNT (p.R45X)
The late stages of CI assembly are impaired.
[107,108,111,145]
Mitochondrial encephalopathy Homozygous: c.1ANT (p.M1L)
L.S. Homozygous: c.114CNG (p.Y38X)
L.S. Homozygous: c.l03delA (p.l35SfsXl7)
L.S. Homozygous: c.221GNA (p.W74X)
NUBPL (Ind1) Mitochondrial encephalopathy Homozygous: c.166GNA (p.G56R) [109,111]
C8orf38 L.S. Homozygous: c.296ANG (p.Q99R) Unknown. [124]
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Table 2 (continued)
Assembly
factor
Patient studies Assembly defect description Ref.
Clinical diagnosis Mutations
FOXRED1 L.S. Compound heterozygous: c.694CNT
(p. Q232X); c.1289ANG (p.N430S)
Unknown. [111,123]
L.S. Homozygous: c.1054CNT (p.R352W)
a LIMD, Lethal Infatile Mitochondrial Disease.
b L.S., Leigh Syndrome, or Leigh-like Syndrome.
c In the ﬁgures, the darkness represents levels of the assembly complexes.
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resulted in fatal neonatal mitochondrial disorders with severe CI
deﬁciency. In mitochondria derived from one of the patients, CI as-
sembly was disrupted without the accumulation of either periph-
eral or membrane arm assembly intermediates. These ﬁndings
suggest that Ndufaf3 plays a role in the early stages of CI assembly.
Furthermore, Ndufaf3 was shown to tightly interact with Ndufaf4
localizing in the membrane [93]. Their membrane localization also
suggests that Ndufaf3 and Ndufaf4 may be involved in membrane
anchoring of an early intermediate complex, which contains the CI
subunits NDUFS2, 3, 7 and 8. Indeed, in BN-PAGE analyses, Ndufaf3
and Ndufaf4 accurately comigrate with a subcomplex containing
NDUFS2, NDUFS3, NDUFS7, NDUFS8 and possibly NDUFA9, suggest-
ing the interaction of these 2 proteins with this subcomplex
[42,93]. At this stage, the early intermediate complex would be as-
sembled with membrane arm intermediates which contain ND1.
Then, this Ndufaf3 and Ndufaf4 intermediate would be assembled into
the ~400 kDa-subcomplex and subsequently into the ~650 kDa- and
~830 kDa-complexes, close to ﬁnalization of the mature holo-CI [93]
(Table 2).3.4. Ndufaf1 (CIA30)
Complex I assembly factors CIA30 and CIA84 were initially identi-
ﬁed in N. crassa as important proteins that are speciﬁcally involved in
the assembly of the membrane arm of CI [30]. While the CIA84 human
homolog, PTCD1, is a negative regulator of mitochondrial leucine
tRNA levels [94], the human homolog of CIA30 (Ndufaf1) has been
established as a bona ﬁde CI assembly factor. Knockdown of Ndufaf1
led to decreased levels of CI activity and assembly [95]. Ndufaf1 is
present in two complexes of ~830 and ~460 kDa [96]. Screening of
patient cells diagnosed with enzymatically deﬁcient CI, revealed a pa-
tient with cardioencephalomyopathy, showing markedly reduced
levels of Ndufaf1. Genetic analysis revealed that the patient had mu-
tations in both alleles of the NDUFAF1 gene [96] (Table 2). Steady-
state CI levels were restored by complementing the deﬁciency in
the patient's ﬁbroblasts with normal Ndufaf1, which showed the path-
ogenicity of the mutations. In this patient, ND2 and the ~460-kDa CI in-
termediate were degraded and the ~830-kDa complex and the CI
holoenzyme were not formed. This ﬁnding suggests that Ndufaf1 is an
important factor for the assembly and/or stability of the ~460-kDa inter-
mediate (Table 2). In normal cells, the ~830-kDa intermediate remains
associated with Ndufaf1 and has been shown by co-immunoprecipita-
tion to contain subunits ND1, ND2, ND3, ND6, NDUFB6, NDUFA6,
NDUFA9, NDUFS3 and NDUFS7 [96]. Recently, the mRNA level and the
protein expression of Ndufaf1 were found to decrease in muscles from
mice lacking testicular nuclear receptor 4 (TR4) [97]. The TR4-knockout
mice developed mitochondrial myopathy with CI deﬁciency and resto-
ration of Ndufaf1 level in themyoblasts from themice increased CI activ-
ity. A chromatin immunoprecipitation assay indicated that TR4 directly
binds to Ndufaf1 promoter. Since TR4 is a key transcriptional regulator
of many signaling pathways, TR4 could modulate CI activity via tran-
scriptionally regulating Ndufaf1 [97].3.5. Ecsit
Evolutionary conserved signaling intermediate in Toll pathways
(Ecsit) was originally identiﬁed as a cytosolic protein involved in
the inﬂammatory response and embryonic development [98,99];
however, it has also been described as a mitochondrial protein that
interacts with Ndufaf1 during CI assembly [100]. Ecsit is found in the
~460- and ~830-kDa intermediates with Ndufaf1. Furthermore, knock-
down of Ecsit using RNAi reduced the levels of Ndufaf1 and led to im-
paired CI assembly. The levels of the intermediates associated with
Ndufaf1 and Ecsit were also reduced following Ecsit knockdown and a
~500-kDa subcomplex accumulated [100] (Table 2). These ﬁndings
suggest that the stability of Ndufaf1 and its associated intermediates is
dependent on Ecsit. Conversely, Ndufaf1 knockdown results in a
minor decrease in the amount of Ecsit in the ~500-kDa intermediate
[100], indicating that Ecsit and Ndufaf1 may have different functions
in CI assembly or stability.
3.6. ACAD9
Acyl-CoA dehydrogenase 9 (ACAD9) was initially cloned and iden-
tiﬁed as a member of the acyl-CoA dehydrogenase family [101]. Con-
trary to its previously proposed involvement in fatty acid oxidation, a
new role for ACAD9 in oxidative phosphorylation was recently dis-
covered. Tandem afﬁnity puriﬁcation demonstrated that ACAD9 was
co-puriﬁed with the known CI assembly factors Ndufaf1 and Ecsit
[100,102]. Subsequent 2-dimensional blue-native SDS-PAGE analysis
showed that ACAD9 co-migrates with the previously described 500–
850-kDa complexes that contain Ndufaf1 and Ecsit [42]. Knockdown
of ACAD9 by RNAi led to decreased levels of CI along with Ndufaf1
and Ecsit, while Ndufaf1 knockdown reduced ACAD9 levels [102].
Moreover, pathogenic mutations in ACAD9 that caused isolated CI de-
ﬁciency in two patients with exercise intolerance, hypertrophic car-
diomyopathy, lactic acidosis and failure to thrive were identiﬁed
(Table 2). Consistent with the results of ACAD9 knockdown, fully as-
sembled CI and Ecsit and Ndufaf1 protein levels were reduced in
ACAD9 patient cell lines [102]. Whole-exome sequencing of a single in-
dividual with severe isolated CI deﬁciency identiﬁed other pathogenic
ACAD9 mutations and subsequent screening of additional patients led
to the identiﬁcation of two additional unrelated caseswith ACAD9muta-
tions [103]. Following this, homozygositymapping using a large consan-
guineous family with an isolated CI deﬁciency led to the identiﬁcation of
a pathogenic homozygous mutation in ACAD9 [104]. Importantly, ribo-
ﬂavin, the vitamin precursor of the ﬂavin adenine dinucleotide (FAD)
moiety, is known to be the catalytic cofactor of ACADs and enhances
their assembly and stability [105]. Beneﬁcial effects of riboﬂavin treat-
ment were reported in some patients [103,104]; therefore, the identiﬁ-
cation of ACAD9 mutations in a patient with CI deﬁciency is extremely
important from a clinical point of view.
How ACAD9, a protein previously proposed to be involved in fatty
acid oxidation, functions in CI maintenance remains unresolved. In-
terestingly, no biochemical evidence of disturbed fatty acid oxidation
was detected in patients with ACAD9 gene mutations [102–104], sug-
gesting that the primary in vivo role of ACAD9 is in the assembly of CI.
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B17.2L was originally identiﬁed as a mitochondrial protein of un-
known function in a screen for transcriptional targets of c-myc
[106]. However, whole genome subtraction identiﬁed B17.2L as a can-
didate factor for CI assembly [107]. This protein is a paralog of
NDUFA12 (B17.2), a small structural subunit in the matrix arm of CI
[1].
Null mutations in B17.2L in a patient with a progressive encephalopa-
thy resulted in CI deﬁciency, and the associated CI assembly defect could
be completely rescued by retroviral expression of B17.2L in the patient
ﬁbroblasts [107] (Table 2). An anti-Ndufaf2 antibody did not associate
with the holoenzyme complex, but speciﬁcally recognized an 830-kDa
subcomplex in several patients with CI assembly defects caused by path-
ogenic mutations in CI subunits NDUFV1 or NDUFS4, which form part of
the Nmodule (Fig. 2). Analyses of mitochondria from patients with mu-
tations in NDUFS6, whose gene product is part of the N module, also
revealed an accumulation of the ~830-kDa subcomplex [72]. However,
this complex was not detected in controls, suggesting that it represents
a stalled assembly intermediate, rather than a degradation product
[41]. In another patient with a homozygous null mutation of NDUFAF2,
the accumulation of subcomplexes containing the NDUFS2 and
NDUFS3 subunits was also detected [108]. Furthermore, Ndufaf2 co-
immunoprecipitated a subset of CI structural subunits including ND1,
NDUFS2, NDUFS3, NDUFS4, NDUFV1, NDUFV2 and NDUFA13 [107].
These ﬁndings suggest that Ndufaf2 is associated with the ~830 kDa-
complex and required in the late stage of CI assembly (Table 2).
3.8. Ind1 (NUBPL)
Fe–S protein required for NADH dehydrogenase (Ind1) or Nucleo-
tide-binding protein-like protein (NUBPL), is an Fe–S protein that con-
tains an N-terminal mitochondrial-targeting sequence, a highly
conserved nucleotide-binding domain, and a putative Fe–S-binding sig-
nature (CXXC) [109,110]. CI contains 8 Fe–S clusters and Ind1 can bind
to an Fe–S cluster via its CXXCmotif [110]. Deletion of Ind1 in Y. lipolytica
results in speciﬁcally decreased CI activity, whereas the activity of other
mitochondrial Fe–S enzymes, e.g., aconitase and succinate dehydroge-
nase, is not affected [109]. Knockdown of human Ind1 in HeLa cells by
RNAi strongly decreased CI protein and enzyme activity levels and mas-
sively decreased the levels of several subunits of the peripheral arm of
CI, such as NDUFS1 and NDUFV1, which contain Fe–S clusters [1], plus
NDUFS3 and NDUFA13 [110]. Furthermore, Ind1 depletion resulted in
the appearance of a 450-kDa subcomplex representing part of the mem-
brane arm. This subcomplex appears to be a stalled membrane arm as-
sembly intermediate that accumulates due to the impaired assembly of
the peripheral arm, including the Fe–S cluster-containing subunits. This
450-kDa subcomplex does not contain NDUFS1, NDUFV1, NDUFA13, or
NDUFA9, but it does contain the membrane arm subunit NDUFB6 [110],
suggesting that this subcomplex likely corresponds to the ~460 kDa-sub-
complex (Fig. 2). As NDUFS7 and NDUFS8 also contain Fe–S clusters, Ind1
depletion might affect the ~400 kDa-subcomplex containing these sub-
units and may impair the assembly of the ~400 kDa-and ~460 kDa-sub-
complexes into larger complexes, resulting in the accumulation of the
460-kDa subcomplex. Radiolabeling using
55
Fe-labeled transferrin, the
physiological source of Fe for mammalian cells, revealed that the amount
of Fe associated with CI reﬂects the dependence of this enzyme on Ind1
for its assembly. Together, these data identify Ind1 as an important factor
for CI assembly, particularly in the assembly ofNmodule and the subcom-
plex containing NDUFS7 and NDUFS8, with a possible role in the delivery
of Fe–S clusters to CI subunits (Table 2).
Recently, high-throughput sequencing of over 100 candidate genes
in more than 100 individuals with CI deﬁciency led to the identiﬁcation
of compound heterozygous mutations in the Ind1 gene in a single pa-
tient [111] (Table 2). The patient presented with developmental delay
accompanied by myopathy, nystagmus, ataxia, upper motor neuronsigns and ﬁndings of leukodystrophy on brain magnetic resonance im-
aging. The transduction of the patient's ﬁbroblasts with wild-type
Ind1 restored CI activity, which conﬁrmed the important role of Ind1
in CI biogenesis.
3.9. AIF
Apoptosis-inducing factor (AIF) was originally identiﬁed as a mi-
tochondrial pro-apoptotic protein. It is an evolutionarily conserved,
ubiquitously expressed ﬂavoprotein with NADH oxidase activity
that is normally located in the mitochondrial intermembrane space
[112]. Upon apoptogenic stimuli, AIF is released from mitochondria
into the cytosol and migrates to the nucleus where it mediates the
nuclear features of apoptosis, e.g., chromatin condensation and large
scale DNA degradation, in a caspase-independent manner [112–114].
Besides its apoptotic role, AIF has been shown to have a physiolog-
ical role in sustaining CI-driven oxidative phosphorylation, indepen-
dently of its pro-apoptotic properties [115–118]. AIF-depleted cells
have reduced levels of CI subunits, decreased CI activity and impaired
CI-driven mitochondrial respiration [116–118]. In mice with a partial
AIF deﬁciency, Harlequin (Hq) mice, the levels of AIF are reduced by
~80% due to a fortuitous retroviral insertion in the ﬁrst intron of the
AIF gene encoding AIF, which is on the X chromosome. Brain mito-
chondria derived from Hq mice display reduced levels of CI and CI
subunits along with defects in CI-driven mitochondrial respiration
[118–120]. These animals exhibit a phenotype associated with mito-
chondrial respiratory chain diseases, including cerebellar ataxia and
retinal degeneration [121], and have been established as a genetic
model of human CI deﬁciency [118]. However, because AIF has not
been found to be associated with any structural subunits of CI and
the generation of incompletely assembled subcomplexes has not
been detected in AIF-deﬁcient mitochondria, the role of AIF in CI bio-
genesis remains elusive.
Recently, a pathological mutation in the human X-linked AIFM1
gene encoding AIF was identiﬁed in 2 infant male patients with pro-
gressive mitochondrial encephalomyopathy [122]. These patients
were born from monozygotic twin sisters and unrelated fathers, sug-
gesting an X-linked trait, and single nucleotide polymorphism-based
haplotype analysis of the X chromosome led to the identiﬁcation of
the mutation. Surprisingly, ﬁbroblasts from the patients showed a re-
duction of respiratory chain complex III and complex IV activity, but
not of CI activity. The mechanism underlying the discrepancy in the
effect of AIF deﬁciency on CI activity between Hqmice and human pa-
tients is not clear. Approximately 75% of mutant cells from the pa-
tients showed mitochondrial fragmentation under galactose
treatment compared with 23% of control cells, suggesting that cells
containing the mutation are more sensitive to apoptotic stimuli
than control cells. The AIFM1 mutation might destabilize the inner
mitochondrial membrane causing subsequent damage to the struc-
ture and activity of the respiratory chain, which is not a speciﬁc effect
on CI assembly/stability. The ﬁndings in the patients' cells will require
the reinterpretation of the role of AIF in CI biogenesis.
3.10. MidA
Mitochondrial dysfunction protein A (MidA) was originally identiﬁed
and characterized in Dictyostelium [123], and reduced levels of ATP and
various phenotypes, including slow growth and abnormal development,
were observed in Dictyostelium lacking MidA. Dictyostelium and human
MidA are highly homologous proteins, and yeast 2-hybrid screening and
pull-down assays recently revealed that both proteins interact with the
CI subunit NDUFS2 [88]. Consistent with this ﬁnding, Dictyostelium
midA null cells showed decreased CI activity, while knockdown of
human MidA in HEK293T cells resulted in reduced levels of assembled
CI in BN-PAGE studies. Interestingly, structural bioinformatic analyses
suggested that MidA has a methyltransferase domain, as does another
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be methylated at an arginine residue. These facts raise the possibility
thatMidAmethylates this subunit as a necessary step in the CI assembly
process.
3.11. Complex I phylogenetic proﬁle genes
Of note is the recent approach to elucidate CI function based on a
comprehensive compendium of the mitochondrial proteome by phylo-
genetic proﬁling of 43 species containing or lacking CI [124]. Complex I
phylogenetic proﬁle (COPP) genes, which have coevolved with CI, were
identiﬁed and 19 strong candidate proteins thatmight be involved in CI
biogenesis were found. Among these proteins, knockdown of C8orf38,
FOXRED1, LYRM5 and LACTB using lentiviral-mediated RNAi reduced
the levels of CI activity [124]. Furthermore, 3 candidate genes, C8orf38
[124], C20orf7 [85] and Ndufaf3 (C3orf60) [93], have been conﬁrmed
to be involved in CI biogenesis, as gene mutations have been found in
patients with CI deﬁciency, which veriﬁed that the COPP genes are
promising candidate CI assembly factors. In addition, pathogenic muta-
tions in another COPP gene, FAD-dependent oxidoreductase domain-
containing protein 1 (FOXRED1), were recently identiﬁed in patients
with isolated CI deﬁciency; however, its exact function remains elusive
[111,125].
4. Current model of human complex I assembly
The accumulation of research ﬁndings for human CI biogenesis al-
lows us to propose a newly updated model for its assembly (Fig. 2,
Table 2). The most recent consensus model proposes that an early as-
sembly intermediate is anchored to the membrane prior to its exten-
sion with additional membrane and peripheral subunits [126].
In the early assembly stage, the core subunits NDUFS2 and NDUFS3
form a small hydrophilic assembly complex, which further expands by
the incorporation of hydrophilic subunits, e.g., NDUFS7, NDUFS8, and
later, possibly NDUFA9. This peripheral complex is anchored to themem-
brane by the assembly factors Ndufaf3 and Ndufaf4 [93]. The complex
combines with a small membrane complex containing the mtDNA-
encodedND1 subunit, forwhich C20orf7 is involved in assembly or stabil-
ity [85], to form a ~400-kDa assembly intermediate [41]. This ~400-kDa
complex incorporates with a ~460-kDa membrane complex containing
ND3, ND6, ND2, ND4L and NDUFB6 to form a ~650-kDa complex under
the presence of the assembly factors of Ndufaf1, Ecsit and ACAD9
[85,102]. With the association of another membrane complex containing
ND4, ND5 and possibly NDUFC2, an ~830 kDa assembly intermediate is
formed [49]. The assembly factor Ndufaf2 is associated with this
~830 kDa-complex andwould be required in the late stage of CI assembly
[107]. Meanwhile, a hydrophilic complex, the NADH: dehydrogenase
module, is builtwith somenDNA-encoded subunits that are directly or in-
directly involved in binding and oxidizingNADH.With the addition of the
NADH: dehydrogenase module and the remaining subunits, the mature
holo-CI is assembled. In this complicated and elaborate assembly process,
more assembly factors with unknown functions including Ind1, MidA,
FOXRED1 and undiscovered proteins are involved [88,111].
5. Closing remarks
Recent remarkable advances in structural biology have given us
new insights into the architecture and function of CI, and in the
near future, they may elucidate the exact composition of CI interme-
diates and clarify the speciﬁc signiﬁcance of the assembly factors in
these complexes for CI assembly/stability.
Furthermore, analyses of patients with deﬁcits in CI subunits or as-
sembly factors have provided a better understanding of the CI assem-
bly process. At present, the genotype–phenotype correlation in
patients with CI deﬁciency is not clear (Tables 1 and 2) [127], so we
need to establish an exhaustive diagnostic system to screen routinelyfor mutations in all of the CI subunits, and both known and candidate
factors that play a role in CI assembly/stability [128]. Recent powerful
technologies such as next generation sequencing or tiling arrays com-
bined with functional validation such as assembly analysis are facili-
tating the identiﬁcation of patients with mutations causing CI
deﬁciency. Continuing concerted efforts to expand knowledge of CI
assembly and to identify all factors involved in this assembly process
are also needed. These achievements are clearly important for the fu-
ture diagnosis and treatment of these patients.
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